Finance

Roʻyxatlar
STAR:NSE
Strides Pharma Science Ltd
962,40 ₹
-1,71%
(-16,70) 1K
20-noy, 15:30:00 (GMT+5:30)  ·   INR
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
STAR tikeri uchun statistika yaratilmoqda...
Ochish
982,00 ₹
Yuqori
982,00 ₹
Past
956,10 ₹
Bozor kapitali
88,71 mlrd
Oʻrtacha hajm
365,19 ming
Hajmi
232,62 ming
Dividend
0,52%
Choraklik dividendlar
1,25 ₹
Eks-dividend sanasi
31-iyl, 2026
P/E koeffitsiyenti
14,39
52 haftalik eng yuqori
1 260,90 ₹
52 haftalik eng past
768,65 ₹
Aksiya boʻyicha daromad
66,90 ₹
Muomaladagi aksiyalar
89,55 mln
Xodimlar soni
4 ming
Ochish
982,00 ₹
Yuqori
982,00 ₹
Past
956,10 ₹
Bozor kapitali
88,71 mlrd
Oʻrtacha hajm
365,19 ming
Hajmi
232,62 ming
Dividend
0,52%
Choraklik dividendlar
1,25 ₹
Eks-dividend sanasi
31-iyl, 2026
P/E koeffitsiyenti
14,39
52 haftalik eng yuqori
1 260,90 ₹
52 haftalik eng past
768,65 ₹
Aksiya boʻyicha daromad
66,90 ₹
Muomaladagi aksiyalar
89,55 mln
Xodimlar soni
4 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies. Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
Strides Pharma Science Ltd haqida
CEO-
Xodimlar soni3,54 ming
Asos solingan1990
Bosh ofislarBangalor, Karnataka, Hindiston
SektorHealth Care
Soha-
Veb-saytstrides.com
Oxirgi hisobot
30-okt, 2026
Moliya davri
Ch.2 2027
- / -
Taxminiy daromad (INR)
14,30 mlrd / 14,15 mlrd
+1,06%musbat
Q2 2027 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – INR
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – INR
dek, 2025
mar, 2026
iyn, 2026
sen, 2026
Daromad
11,95 mlrd
13,23 mlrd
12,65 mlrd
14,30 mlrd
Sotilgan mahsulotning tannarxi
4,63 mlrd
7,19 mlrd
4,95 mlrd
6,29 mlrd
Daromad narxi
4,63 mlrd
7,19 mlrd
4,95 mlrd
6,29 mlrd
Tadqiqot va ishlanmalarga xarajatlar
-
-
-
-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
2,30 mlrd
3,45 mlrd
2,43 mlrd
2,38 mlrd
Operatsion xarajatlar
5,46 mlrd
4,91 mlrd
5,97 mlrd
6,07 mlrd
Jami operatsion xarajatlar
10,09 mlrd
12,10 mlrd
10,92 mlrd
12,36 mlrd
Operatsion daromad
1,85 mlrd
1,13 mlrd
1,73 mlrd
1,94 mlrd
Boshqa nooperatsion daromad
1,07 mlrd
-1,66 mlrd
48,90 mln
40,83 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
2,45 mlrd
1,48 mlrd
2,00 mlrd
1,50 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
2,49 mlrd
502,07 mln
1,36 mlrd
1,52 mlrd
Daromad soligʻi boʻyicha xarajat
373,53 mln
187,70 mln
341,23 mln
163,18 mln
Amaldagi soliq stavkasi
15,22%
12,68%
17,09%
10,85%
Boshqa operatsion xarajatlar
2,66 mlrd
928,53 mln
2,97 mlrd
3,11 mlrd
Sof foyda
2,02 mlrd
1,27 mlrd
1,57 mlrd
1,31 mlrd
Sof foyda marjasi
16,92%
9,59%
12,40%
9,15%
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
-
404,82 mln
-
-
Foizlarni toʻlash xarajatlari
-433,79 mln
-130,82 mln
-405,61 mln
-465,41 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-433,79 mln
274,00 mln
-405,61 mln
-465,41 mln
Amortizatsiya ajratmalari
506,23 mln
532,49 mln
563,99 mln
572,15 mln
EBITDA
2,25 mlrd
1,55 mlrd
2,15 mlrd
2,51 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
Kelgusi tadbirlar
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari